Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Vitamin D deficiency, autoimmunity, and graft-versus-host-disease risk: Implication for preventive therapy.

Benrashid M, Moyers K, Mohty M, Savani BN.

Exp Hematol. 2012 Apr;40(4):263-7. doi: 10.1016/j.exphem.2012.01.006. Epub 2012 Jan 17. Review.

PMID:
22265707
3.

Immunomodulatory effects of vitamin D: implications for GVHD.

Rosenblatt J, Bissonnette A, Ahmad R, Wu Z, Vasir B, Stevenson K, Zarwan C, Keefe W, Glotzbecker B, Mills H, Joyce R, Levine JD, Tzachanis D, Boussiotis V, Kufe D, Avigan D.

Bone Marrow Transplant. 2010 Sep;45(9):1463-8. doi: 10.1038/bmt.2009.366. Epub 2010 Jan 18.

PMID:
20081878
4.

Acute graft-vs-host disease: pathobiology and management.

Goker H, Haznedaroglu IC, Chao NJ.

Exp Hematol. 2001 Mar;29(3):259-77. Review. Erratum in: Exp Hematol 2001 May;29(5):653.

PMID:
11274753
5.

Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation.

Mohty M, Gaugler B.

Cytokine Growth Factor Rev. 2008 Feb;19(1):53-63. Epub 2007 Dec 20. Review.

PMID:
18083060
6.

Management of acute graft versus host disease (GvHD).

Bacigalupo A, Palandri F.

Hematol J. 2004;5(3):189-96. Review.

PMID:
15167903
7.

Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity.

Zhang Y, Joe G, Zhu J, Carroll R, Levine B, Hexner E, June C, Emerson SG.

Blood. 2004 May 15;103(10):3970-8. Epub 2004 Feb 5.

9.

Understanding the alloresponse: new approaches to graft-versus-host disease prevention.

Teshima T, Ferrara JL.

Semin Hematol. 2002 Jan;39(1):15-22. Review.

PMID:
11799525
10.

Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.

Tian Y, Deng YB, Huang YJ, Wang Y.

Immunol Invest. 2008;37(1):29-42. doi: 10.1080/08820130701410223.

PMID:
18214798
11.

Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.

Talmadge JE.

Int Immunopharmacol. 2003 Aug;3(8):1121-43. Review.

PMID:
12860168
12.

Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation.

Soiffer RJ, Gonin R, Murray C, Robertson MJ, Cochran K, Chartier S, Cameron C, Daley J, Levine H, Nadler LM, et al.

Blood. 1993 Oct 1;82(7):2216-23.

13.

B cell homeostasis and the development of chronic graft-versus-host disease: implications for B cell-depleting therapy.

Kim SJ, Won JH.

Leuk Lymphoma. 2012 Jan;53(1):19-25. doi: 10.3109/10428194.2011.603448. Epub 2011 Sep 6. Review.

PMID:
21740304
14.

Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.

MacDonald KP, Rowe V, Filippich C, Thomas R, Clouston AD, Welply JK, Hart DN, Ferrara JL, Hill GR.

Blood. 2003 Mar 1;101(5):2033-42. Epub 2002 Oct 17.

15.

Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients.

Heining C, Spyridonidis A, Bernhardt E, Schulte-Mönting J, Behringer D, Grüllich C, Jakob A, Bertz H, Finke J.

Bone Marrow Transplant. 2007 May;39(10):613-22. Epub 2007 Mar 26.

PMID:
17384658
16.

Improving immune reconstitution while preventing graft-versus-host disease in allogeneic stem cell transplantation.

Cavazzana-Calvo M, André-Schmutz I, Hacein-Bey-Abina S, Bensoussan D, Le Deist F, Fischer A.

Semin Hematol. 2002 Jan;39(1):32-40. Review.

PMID:
11799527
17.

Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.

Chen G, Wu D, Wang Y, Cen J, Feng Y, Sun A, Tang X, Chang H, Zhu Z.

Eur J Haematol. 2008 Sep;81(3):226-35. doi: 10.1111/j.1600-0609.2008.01108.x. Epub 2008 Jun 28.

PMID:
18573173
18.

Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.

Lo JW, Leung AY, Huang XR, Lie AK, Metz C, Bucala R, Liang R, Lan HY.

Bone Marrow Transplant. 2002 Sep;30(6):375-80.

20.

Review: vitamin D, immunity and lupus.

Cutolo M, Otsa K.

Lupus. 2008 Jan;17(1):6-10. Review.

PMID:
18089676
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk